Company / Total Assets
Vaxcyte, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$3.0B
FY2025
5-year range
$324.3M / $3.5B
FY2021-FY2025
Trend
-14.5%
vs FY2024
Sector context
#32 of 214
Health Care
What the data says
Vaxcyte, Inc.'s total assets of $3.0B is higher than 85% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 7 years, ranging from $66M in FY2019 to $3.5B in FY2024.
Based on SEC 10-K filings.
$3.0B in FY2025 with a 5-year CAGR of +50.2%. Top quartile in the Health Care sector.
Improved from $1.4B to $3.0B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +44.0%
- 5-Year CAGR
- +50.2%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 214This company $3.0B Sector average $7.5B
▼
-59.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +50.2%, indicating consistent growth.
- In FY2025, total assets decreased 14.5% year-over-year.
- Ranks #32 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.0B | -14.5% |
| FY2024 | $3.5B | +149.4% |
| FY2023 | $1.4B | +39.9% |
| FY2022 | $1.0B | +210.2% |
| FY2021 | $324.3M | -17.4% |
| FY2020 | $392.8M | +497.9% |
| FY2019 | $65.7M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026